2 completed, 1 not yet recruiting, 1 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Hovid Berhad: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD) Palm Tocotrienol Rich Fraction (TRF), Refined, bleached, and deodorised (RBD) palm olein - Alcoholic Fatty Liver Disease | Phase 2 | Not yet recruiting | Universiti Kebangsaan Malaysia Medical Centre | 26 | 2026-05-02 | 2026-04-29 |
| Ivermectin for Post Exposure Prophylaxis of Covid-19 Ivermectin, Placebo - COVID-19 | Phase 3 | Terminated | Clinical Research Centre, Malaysia | 50 | 2022-02-16 | 2022-10-18 |
| Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) Tocotrienols / Vitamin E, Placebo control - Hepatic Steatosis, NAFLD | Phase 2 | Completed | Yuen Kah Hay | 170 | 2021-01-01 | 2024-05-10 |
| Efficacy and Safety of Tocotrienols in CADASIL HOV-12020 (Palm tocotrienols complex), Placebo - Cadasil | Phase 2 | Completed | Hovid Berhad | 50 | 2020-12-21 | 2026-02-02 |
CADASIL (1) · COVID-19 (1) · Cerebral Small Vessel Diseases (1) · Cerebrovascular Disorders (1) · Cognitive Dysfunction (1) · Dementia (1) · Fatty Liver (1) · Fatty Liver, Alcoholic (1) · Liver Diseases (1) · Non-alcoholic Fatty Liver Disease (1) · Stroke (1)
Tocotrienols (2) · Ivermectin (1) · Vitamin E (1)
Malaysia (3) · France (1)
David Ho (1) · Kah Hay Yuen, PhD (1) · Pr Hugues Chabriat (1)